Niacinamide and Neuroprotection: The Glaucoma Holy Grail

doi:10.5005/jp-journals-10078-1390

Editorial

. 2022 Sep-Dec;16(3):141-143.

doi: 10.5005/jp-journals-10078-1390.

Niacinamide and Neuroprotection: The Glaucoma Holy Grail

Shibal Bhartiya¹

Affiliations

PMID: 36793265
PMCID: PMC9905873
DOI: 10.5005/jp-journals-10078-1390

Editorial

Niacinamide and Neuroprotection: The Glaucoma Holy Grail

Shibal Bhartiya. J Curr Glaucoma Pract. 2022 Sep-Dec.

. 2022 Sep-Dec;16(3):141-143.

doi: 10.5005/jp-journals-10078-1390.

Author

Shibal Bhartiya¹

Affiliation

¹ Department of Ophthalmology, Fortis Memorial Research Institute (FMRI) Gurgaon, Haryana, India.

PMID: 36793265
PMCID: PMC9905873
DOI: 10.5005/jp-journals-10078-1390

Abstract

How to cite this article: Bhartiya S. Niacinamide and Neuroprotection: The Glaucoma Holy Grail. J Curr Glaucoma Pract 2022;16(3):141-143.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

Cited by

Current perspectives in tackling glaucoma blindness.
Bhartiya S, Ichhpujani P, Wadhwani M. Bhartiya S, et al. Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S189-S196. doi: 10.4103/IJO.IJO_3280_23. Epub 2025 Feb 21. Indian J Ophthalmol. 2025. PMID: 39982079 Free PMC article. Review.
Retinal ischemic diseases and promising therapeutic molecular targets.
Lee D, Tomita Y, Negishi K, Kurihara T. Lee D, et al. Histol Histopathol. 2025 Jan;40(1):11-20. doi: 10.14670/HH-18-756. Epub 2024 May 3. Histol Histopathol. 2025. PMID: 38738342 Review.
Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma.
Melecchi A, Amato R, Dal Monte M, Rusciano D, Bagnoli P, Cammalleri M. Melecchi A, et al. Front Med (Lausanne). 2023 Sep 5;10:1230941. doi: 10.3389/fmed.2023.1230941. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37731716 Free PMC article.

References

1. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed
1. Morgan JE. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin Exp Ophthalmol. 2012;40(4):364–368. doi: 10.1111/j.1442-9071.2012.02789.x. - DOI - PubMed
1. Williams PA, Harder JM, Foxworth NE, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756–760. doi: 10.1126/science.aal0092. - DOI - PMC - PubMed
1. Tribble JR, Vasalauskaite A, Redmond T, et al. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 2019;1(1):fcz035. doi: 10.1093/braincomms/fcz035. - DOI - PMC - PubMed
1. Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, et al. Nicotinamide deficiency in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(7):2509–2514. doi: 10.1167/iovs.19-27099. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed

[2] Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi: 10.1016/j.ophtha.2014.05.013. - DOI - PubMed

[3] Morgan JE. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin Exp Ophthalmol. 2012;40(4):364–368. doi: 10.1111/j.1442-9071.2012.02789.x. - DOI - PubMed

[4] Morgan JE. Retina ganglion cell degeneration in glaucoma: an opportunity missed? A review. Clin Exp Ophthalmol. 2012;40(4):364–368. doi: 10.1111/j.1442-9071.2012.02789.x. - DOI - PubMed

[5] Williams PA, Harder JM, Foxworth NE, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756–760. doi: 10.1126/science.aal0092. - DOI - PMC - PubMed

[6] Williams PA, Harder JM, Foxworth NE, et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756–760. doi: 10.1126/science.aal0092. - DOI - PMC - PubMed

[7] Tribble JR, Vasalauskaite A, Redmond T, et al. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 2019;1(1):fcz035. doi: 10.1093/braincomms/fcz035. - DOI - PMC - PubMed

[8] Tribble JR, Vasalauskaite A, Redmond T, et al. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 2019;1(1):fcz035. doi: 10.1093/braincomms/fcz035. - DOI - PMC - PubMed

[9] Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, et al. Nicotinamide deficiency in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(7):2509–2514. doi: 10.1167/iovs.19-27099. - DOI - PubMed

[10] Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, et al. Nicotinamide deficiency in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2019;60(7):2509–2514. doi: 10.1167/iovs.19-27099. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Niacinamide and Neuroprotection: The Glaucoma Holy Grail

Affiliation

Niacinamide and Neuroprotection: The Glaucoma Holy Grail

Author

Affiliation

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources